| Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice F Guida, F Turco, M Iannotta, D De Gregorio, I Palumbo, G Sarnelli, ... Brain, behavior, and immunity 67, 230-245, 2018 | 311 | 2018 |
| Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia J Tack, P Caenepeel, H Piessevaux, R Cuomo, J Janssens Gut 52 (9), 1271-1277, 2003 | 286 | 2003 |
| Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation G Esposito, E Capoccia, F Turco, I Palumbo, J Lu, A Steardo, R Cuomo, ... Gut 63 (8), 1300-1312, 2014 | 272 | 2014 |
| Italian consensus conference for colonic diverticulosis and diverticular disease R Cuomo, G Barbara, F Pace, V Annese, G Bassotti, GA Binda, T Casetti, ... United European gastroenterology journal 2 (5), 413-442, 2014 | 234 | 2014 |
| Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis D De Filippis, G Esposito, C Cirillo, M Cipriano, BY De Winter, C Scuderi, ... PloS one 6 (12), e28159, 2011 | 223 | 2011 |
| Enteroglial-derived S100B protein integrates bacteria-induced Toll-like receptor signalling in human enteric glial cells F Turco, G Sarnelli, C Cirillo, I Palumbo, F De Giorgi, A D'Alessandro, ... Gut 63 (1), 105-115, 2014 | 193 | 2014 |
| Functional variants in the sucrase–isomaltase gene associate with increased risk of irritable bowel syndrome M Henström, L Diekmann, F Bonfiglio, F Hadizadeh, EM Kuech, ... Gut 67 (2), 263-270, 2018 | 187 | 2018 |
| Enteric glial cells: a new frontier in neurogastroenterology and clinical target for inflammatory bowel diseases F Ochoa-Cortes, F Turco, A Linan-Rico, S Soghomonyan, E Whitaker, ... Inflammatory bowel diseases 22 (2), 433-449, 2016 | 175 | 2016 |
| Loss-of-function of the voltage-gated sodium channel NaV1. 5 (channelopathies) in patients with irritable bowel syndrome A Beyder, A Mazzone, PR Strege, DJ Tester, YA Saito, CE Bernard, ... Gastroenterology 146 (7), 1659-1668, 2014 | 173 | 2014 |
| Pathophysiology of gastro-oesophageal reflux disease F De Giorgi, M Palmiero, I Esposito, F Mosca, R Cuomo Acta Otorhinolaryngologica Italica 26 (5), 241, 2006 | 173 | 2006 |
| Effects of long‐term PPI treatment on producing bowel symptoms and SIBO D Compare, L Pica, A Rocco, F De Giorgi, R Cuomo, G Sarnelli, ... European journal of clinical investigation 41 (4), 380-386, 2011 | 172 | 2011 |
| Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders C Eijsbouts, T Zheng, NA Kennedy, F Bonfiglio, CA Anderson, ... Nature genetics 53 (11), 1543-1552, 2021 | 171 | 2021 |
| S100B protein in the gut: the evidence for enteroglial-sustained intestinal inflammation. C Cirillo, G Sarnelli, F Turco, R Cuomo, G Esposito, L Steardo World J Gastroenterol 17 (10), 1261-1266, 2011 | 156 | 2011 |
| Functional dyspepsia symptoms, gastric emptying and satiety provocative test: analysis of relationships R Cuomo, G Sarnelli, R Grasso, D Bruzzese, R Pumpo, M Salomone, ... Scandinavian journal of gastroenterology 36 (10), 1030-1036, 2001 | 145 | 2001 |
| Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia I Gockel, J Becker, MM Wouters, S Niebisch, HR Gockel, T Hess, ... Nature genetics 46 (8), 901-904, 2014 | 140 | 2014 |
| Cannabidiol in inflammatory bowel diseases: a brief overview G Esposito, DD Filippis, C Cirillo, T Iuvone, E Capoccia, C Scuderi, ... Phytotherapy Research 27 (5), 633-636, 2013 | 138 | 2013 |
| Increased mucosal nitric oxide production in ulcerative colitis is mediated in part by the enteroglial‐derived S100B protein C Cirillo, G Sarnelli, G Esposito, M Grosso, R Petruzzelli, P Izzo, G Calì, ... Neurogastroenterology & Motility 21 (11), 1209-e112, 2009 | 138 | 2009 |
| Irritable bowel syndrome and food interaction R Cuomo, P Andreozzi, FP Zito, V Passananti, G De Carlo, G Sarnelli World journal of gastroenterology: WJG 20 (27), 8837, 2014 | 137 | 2014 |
| Randomised controlled trial of mesalazine in IBS G Barbara, C Cremon, V Annese, G Basilisco, F Bazzoli, M Bellini, ... Gut 65 (1), 82-90, 2016 | 133 | 2016 |
| Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease–efficacy of Esoxx, a hyaluronic acid–chondroitin … V Savarino, F Pace, C Scarpignato, Esoxx Study Group, M Astegiano, ... Alimentary pharmacology & therapeutics 45 (5), 631-642, 2017 | 132 | 2017 |
Sarnelli GUniversity of Naples Federico IIEmail verificata su unina.it
